Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Non-Current Deferred Tax Liability (2010 - 2017)

Siga Technologies' (SIGA) quarterly Non-Current Deferred Tax Liability came in at $306449.0 in Q3 2017, up 8.71% on a YoY basis from $281889.0 in Q3 2016, and little changed quarter-over-quarter from $307256.0 in Q2 2017.

Analysis

Siga Technologies (SIGA) Non-Current Deferred Tax Liability (2010 - 2017) Analysis & Trends

Siga Technologies (SIGA) has reported Non-Current Deferred Tax Liability for 5 consecutive years, with $306449.0 the latest figure, recorded in Q3 2017.

  • For the quarter ending Q3 2017, Non-Current Deferred Tax Liability rose 8.71% year-over-year to $306449.0; the trailing twelve-month figure through Sep 2017 stood at $306449.0 (up 8.71% YoY), and the FY2016 full-year result was $286066.0, up 7.69% from the prior year.
  • Non-Current Deferred Tax Liability steadied at $306449.0 in Q3 2017 per SIGA's latest filing, from $307256.0 in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $7.5 million in Q3 2015 and bottomed at $240973.0 in Q3 2014.
  • Historically, Non-Current Deferred Tax Liability has averaged $1.8 million across 4 years, with a median of $286066.0 in 2016.
  • The sharpest annual moves came in 2015 and 2016: Non-Current Deferred Tax Liability soared 3020.62% in 2015, then plunged 96.25% in 2016.
  • Over 4 years, Non-Current Deferred Tax Liability stood at $244540.0 in 2014, then grew by 8.63% to $265643.0 in 2015, then advanced by 7.69% to $286066.0 in 2016, then gained by 7.13% to $306449.0 in 2017.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $306449.0, $307256.0, and $307256.0 for Q3 2017, Q2 2017, and Q1 2017 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn
10 Siga Technologies 220.19 Mn 65.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 306,449.00
Jun 30, 2017 307,256.00
Mar 31, 2017 307,256.00
Dec 31, 2016 286,066.00
Sep 30, 2016 281,889.00
Jun 30, 2016 277,088.00
Mar 31, 2016 277,895.00
Dec 31, 2015 265,643.00
Sep 30, 2015 7.52 Mn
Jun 30, 2015 7.07 Mn
Mar 31, 2015 6.50 Mn
Dec 31, 2014 244,540.00
Sep 30, 2014 240,973.00
Dec 31, 2010 175,175.00